Bristol Will Buy Diabetes Drug Maker

Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease.

  • Merck's Keytruda Could Soon Be Worth $16 Billion As It Flies Past Bristol's Opdivo
    Rubin upgraded Merck to a buy rating from neutral, and added the stock to the ... Merck could also seek mergers to further diversify, especially as diabetes drug Januvia looks likely to see generic competition in the mid-2020s, Rubin said.
    04/23/2018 - 5:25 am | View Link
  • Pfizer's Deal Potential Doesn't Stop at Bristol-Myers
    The Viagra maker is by far the most megadeal-prone company in the pharmaceutical industry, as evidenced by its pursuit of drug giants AstraZeneca PLC in ... In the meantime, Pfizer is likely to buy back more stock and management is confident in its ...
    04/12/2018 - 8:30 am | View Link
  • AstraZeneca to Buy Bristol’s Stake in Diabetes Joint Venture
    AstraZeneca (AZN) agreed on Thursday to buy Bristol-Myers Squibb’s ... an advisory panel recommended that the U.S. Food and Drug Administration approve dapagliflozin, an experimental treatment for Type 2 diabetes. A similar treatment from Johnson ...
    12/19/2013 - 10:03 pm | View Link
  • AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 billion
    LONDON (Reuters) - AstraZeneca has agreed to buy Bristol-Myers Squibb’s stake in the ... received a boost when an advisory panel to the U.S. Food and Drug Administration endorsed its new diabetes pill dapagliflozin.
    12/18/2013 - 11:00 am | View Link
  • Bristol-Myers Squibb starts Amylin tender offer
    NEW YORK (AP) — Bristol-Myers Squibb Co. is starting a tender offer to buy all of the outstanding shares of diabetes drug maker Amylin Pharmaceuticals Inc. Late last month, Bristol-Myers Squibb said that it planned to buy San Diego-based Amylin for ...
    07/10/2012 - 4:51 am | View Link
  • More
  • New Combo Drugs Control Diabetes: Diabetes Forecast®
    New Combo Drugs Control Diabetes. ... a person with diabetes will need to purchase each drug separately—with two different ... Takeda, Bristol-Myers Squibb ...
    04/19/2018 - 7:53 am | View Website
  • Bristol-Myers Squibb (BMS)
    Bristol-Myers Squibb ... to Eliquis and the Type 2 diabetes drug Farxiga grow, Bristol-Myers may ... over the years to buy or partner with other drug ...
    05/1/2014 - 7:39 am | View Website
  • BMS Sells Diabetes Business to AstraZeneca for Up to $4B ...
    BMS Sells Diabetes Business to AstraZeneca for Up to $4B+ Bristol-Myers Squibb (BMS ... and commercial plans for several commercial and late-stage diabetes drugs.
    12/18/2013 - 6:58 pm | View Website
  • Bristol-Myers to Buy Diabetes Drug Maker Amylin for $5.3Bn
    Bristol-Myers Squibb and Amylin Pharmaceuticals have announced that the global biopharmaceutical giant is set to acquire the diabetes drug maker for approximately $5.3 billion.
    07/2/2012 - 7:54 pm | View Website
  • Bristol-Myers to buy diabetes drug maker for bill US$5 ...
    NEW YORK—Drug maker Bristol-Myers Squibb Co says it agreed to buy diabetes drug maker Amylin Pharmaceuticals for about US$5 billion in cash. Bristol-Myers says it will pay US$31 per share for Amylin in a cash tender offer.
    07/1/2012 - 7:55 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News